Fig. 2From: Efficacy and safety of concurrent chemoradiotherapy in ECOG 2 patients with locally advanced non-small-cell lung cancer: a subgroup analysis of a randomized phase III trialForest plot of HRs for overall survival by prognostic factors. PC = paclitaxel/carboplatin; EP = etoposide/cisplatin; HR = hazard ratio; CI = confidence intervalBack to article page